2003

May 12, 2003
CMS Recommends Guidant Proposal for New DRG for Heart Failure Patients

Establishment of New DRG 535 is Milestone in Advancement of Heart Failure Therapy Indianapolis, Ind. and St. Paul, Minn. - Guidant Corporation (NYSE: GDT), a world leader in the treatment of...

May 9, 2003
Guidant to Host Mid-Quarter Conference Call

Live Webcast Available Indianapolis, Ind. - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and vascular disease, will host a mid-quarter conference call to provide an...

May 8, 2003
Guidant Announces CE Mark and First Implant of Newest Cardiac Resynchronization Pacemaker

The CONTAK RENEWAL TR 2 Implantable Cardiac Resynchronization Therapy Pacemaker Offers Market-leading Diagnostics and Therapy Indianapolis, Ind. and St. Paul, Minn. - Guidant Corporation (NYSE:...

May 8, 2003
Guidant Launches Next Generation Carotid Embolic Protection System in Europe

New Device Captures Emboli Released During Carotid Stenting Indianapolis, Ind. and Menlo Park, Calif. - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and vascular...

May 7, 2003
New Study of Guidant Therapy Shows Significant Decrease in Duration of Postoperative Atrial Fibrillation

Results Presented at American Association of Thoracic Surgeon''s 83rd Annual Meeting Indianapolis, Ind. and Santa Clara, Calif. - Guidant Corporation (NYSE: GDT), a world leader in the treatment...

May 7, 2003
Guidant and ResMed to Develop Complementary Diagnostics and Therapies for Overlapping Patient Populations

Strategic Alliance Aimed at Expanding Options for the Treatment of Sleep-Disordered Breathing Indianapolis, Ind. - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and...

Apr 29, 2003
Guidant to Participate in Deutsche Bank Securities 28th Annual Healthcare Conference

Presentation Accessible Via Webcast Indianapolis, Ind. - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and vascular disease, today announced that it will participate...

Apr 24, 2003
Ginger L. Graham to Leave Guidant to Pursue Other Interests

Indianapolis, Ind. - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and vascular disease, today announced that Ginger L. Graham, Advisor to the President, has elected...

Apr 16, 2003
Guidant Reports First Quarter Record Sales of $885 Million, Growth of 25 Percent

Worldwide Implantable Defibrillator Revenue Growth of 72 Percent Changes Product Mix Indianapolis, Ind. - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and vascular...

Apr 10, 2003
Guidant Sponsors Fellows Course to Educate Future Interventional Cardiologists

International Symposium Covers Latest Techniques and Technologies for Treating Coronary and Peripheral Vascular Disease Indianapolis, Ind. and Santa Clara, Calif. - Guidant Corporation (NYSE:...

Apr 8, 2003
Guidant Announces Live Webcast of its First Quarter Earnings Conference Call

Indianapolis, Ind. - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and vascular disease, will conduct a live webcast of its first quarter 2003 earnings conference...

Apr 1, 2003
Guidant Acquires Majority Stake in Bioabsorbable Stent Company

Indianapolis, Ind. - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and vascular disease, today announced that Guidant will acquire an early-stage company founded by...

Apr 1, 2003
Guidant Announces FDA Approval of Next-Generation Implantable Defibrillator

VITALITY AVT Implantable Defibrillator Offers Complete Ventricular and Atrial Therapy Options Indianapolis, Ind. and St. Paul, Minn. - Guidant Corporation (NYSE: GDT), a world leader in the...

Mar 31, 200
COMPANION Trial Results Announced at Late Breaking Scientific Session at the American College of Cardiology 52nd Annual Scientific Session

Preliminary Data Demonstrate Mortality Benefit and Reduced Hospitalization for Heart Failure Patients CHICAGO - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and...

Mar 31, 2003
Guidant Voluntarily Recalls Stent System

Limited European and Australian Accounts Affected Indianapolis, Ind. - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and vascular disease, today announced that it has...

Mar 30, 2003
Guidant Reports Positive Six-Month Clinical Results of Everolimus Eluting Coronary Stent

Data Supports Use of Everolimus for Drug Eluting Stents Indianapolis, Ind. - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and vascular disease, today announced...

Mar 30, 2003
Guidant Announces Preliminary 30-Day Results of Study of Carotid Artery Stenting as Alternative Treatment for High Surgical-Risk Patients

Study Evaluates Potential New Minimally Invasive Treatment for Carotid Artery Disease Indianapolis, Ind. and Menlo Park, Calif. - Guidant Corporation (NYSE: GDT), a world leader in the treatment...

Mar 28, 2003
Guidant Reports Results of Preclinical Study of Stents for Treatment of Vulnerable Plaque

Study Evaluates Therapeutic Options for Preventing Heart Attacks Indianapolis, Ind. - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and vascular disease, today...

Mar 19, 2003
Guidant Signs Definitive Agreement to Acquire Biosensors' Everolimus Eluting Stent Assets

Company Updates Status of Drug Eluting Stent Program Webcast/Conference Call Scheduled for Thursday, March 20, at 11:00 AM ET Indianapolis, Ind. - Guidant Corporation (NYSE: GDT), a world leader...

Mar 19, 2003
Guidant to Host Investor Briefing at American College of Cardiology Meeting

Live Webcast Available Indianapolis, Ind. - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and vascular disease, announced today that it will host an investor briefing...

Mar 13, 2003
Guidant Announces First Implant in New Heart Failure Scientific Study

U.S. Study Continues Guidant''s Leadership in Clinical Science St. Paul, Minn. and Indianapolis, Ind. - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and vascular...

Mar 12, 2003
Guidant Launches Fifth-Generation System in Japan

MULTI-LINK PENTA Stent System Brings Guidant''s Outstanding Stent Design Technology to Japanese Physicians and Patients Indianapolis, Ind. and Tokyo - Guidant Corporation (NYSE: GDT), a world...

Mar 11, 2003
Guidant Acquires Innovative Interventional Technology

FX miniRAIL Coronary Device Aims to Expand Physicians'' Options In the Treatment of De Novo Lesions and In-Stent Restenosis Indianapolis, Ind. - Guidant Corporation (NYSE: GDT), a world leader in...

Mar 11, 2003
Guidant Appoints Dana G. Mead, Jr. President, Vascular Intervention

Indianapolis, Ind. - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and vascular disease, today announced that Dana G. Mead, Jr., currently vice president, Corporate...

Feb 25, 2003
Guidant to Participate in the Lehman Brothers Global Healthcare Conference

Presentation Accessible Via Webcast Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiac and vascular disease, today announced that it will...

Show per page

Top